The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 17, 2024

Filed:

Aug. 09, 2018
Applicant:

Bioverativ Therapeutics Inc., Waltham, MA (US);

Inventors:

Alexey Seregin, Westford, MA (US);

Tongyao Liu, Lexington, MA (US);

Susannah Patarroyo-White, Waltham, MA (US);

Douglas Drager, Waltham, MA (US);

Robert T. Peters, Needham, MA (US);

Jiayun Liu, Wellesley, MA (US);

Assignee:

BIOVERATIV THERAPEUTICS INC., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C07K 14/755 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/755 (2013.01); C12N 2750/14143 (2013.01);
Abstract

The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a miRNA and/or a therapeutic protein. In certain embodiments, the therapeutic protein comprises a clotting factor, e.g., a FVIII polypeptide, a FIX polypeptide, or a fragment thereof. In some embodiments, the first ITR and/or the second ITR is an ITR of a non-adeno-associated virus (AAV). The present disclosure also provides methods of treating bleeding disorders such as hemophilia comprising administering to the subject the nucleic acid molecule or a polypeptide encoded thereby.


Find Patent Forward Citations

Loading…